Unicycive Therapeutics, Inc. (UNCY)
NASDAQ: UNCY · Real-Time Price · USD
4.960
+0.190 (3.98%)
At close: Sep 22, 2026, 4:00 PM EDT
4.990
+0.030 (0.60%)
After-hours: Sep 22, 2026, 7:39 PM EDT
Unicycive Therapeutics Market Cap
Unicycive Therapeutics has a market cap or net worth of $138.16 million as of September 22, 2026. Its market cap has increased by 97.54% in one year.
Market Cap
138.16M
Enterprise Value
77.41M
1-Year Change
97.54%
Ranking
Category
Stock Price
$4.96
ChartMarket Cap Chart
Since the IPO on July 13, 2021, Unicycive Therapeutics's market cap has increased from $66.49M to $138.16M, an increase of 107.80%. That is a compound annual growth rate of 15.11%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 22, 2026 | 138.16M | 11.42% |
| Dec 31, 2025 | 124.01M | 50.43% |
| Dec 31, 2024 | 82.44M | 173.36% |
| Dec 29, 2023 | 30.16M | 270.11% |
| Dec 30, 2022 | 8.15M | -73.58% |
| Dec 31, 2021 | 30.84M | -53.61% |
| Jul 13, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Immunic | 147.91M |
| Neumora Therapeutics | 146.28M |
| Spruce Biosciences | 143.67M |
| Caribou Biosciences | 143.66M |
| NRx Pharmaceuticals | 143.63M |
| MediciNova | 142.74M |
| enGene Therapeutics | 137.38M |
| TuHURA Biosciences | 135.74M |